70 Results

People

  1. Giralt
    Giralt
  2. Hassoun
    Hassoun
  3. Landau
    Landau
  4. Chung
    Chung
  5. Korde
    Korde
  6. Lesokhin
    Lesokhin
  7. Mailankody
    Mailankody
  8. Scordo
    Scordo
  9. Shah
    Shah
  10. Lahoud
    Lahoud

Groups

  1. Bone Marrow Transplant (70)
  2. Center for Hematologic Malignancies (70)
  3. Department of Medicine (70)
  4. Hematologic Malignancies Research (70)
  5. Hematologic Malignancies, Division of (70)
  6. Myeloma (70)
  7. Survivorship Research (70)
  8. CTCR Scholars (68)
  9. Sloan Kettering Institute Postdocs (68)
  10. Epidemiology and Biostatistics (54)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Hani Hassoun"
  4. "Sergio Giralt"
  5. "Oscar Lahoud"
Formats
  1. Meeting Abstract (56)
  2. Journal Article (11)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Bone Marrow Transplant (70)
  2. Center for Hematologic Malignancies (70)
  3. Department of Medicine (70)
  4. Hematologic Malignancies Research (70)
  5. Hematologic Malignancies, Division of (70)
  6. Myeloma (70)

More Groups

People
  1. Hani Hassoun (70)
  2. Heather Landau (70)
  3. Oscar Lahoud (70)
  4. Sergio Giralt (70)
  5. Alexander Lesokhin (69)
  6. David Chung (69)

More People

Years
  1. 2023 (28)
  2. 2022 (20)
  3. 2021 (7)
  4. 2020 (8)
  5. 2019 (4)
  6. 2018 (3)
Publications
  1. Blood (28)
  2. Clinical Lymphoma, Myeloma and Leukemia (22)
  3. Journal of Clinical Oncology (5)
  4. American Journal of Hematology (2)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (26)
  3. American Society of Clinical Oncology (5)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (70)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Carfilzomib,lenalidomide and dexamethasone (KRd) as induction therapy in high-risk newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Korde, N.; Derkach, A.; Hultcrantz, M.; Maclachlan, K. H.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating the effect of evolving changes in serum biomarkers on the risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K. H.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A comparative analysis of infectious complications in patients with multiple myeloma treated with BCMA-targeted bispecific antibodies and CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Shekarkhand, T.; Costa, B. A.; Nemirovsky, D.; Derkach, A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D.; Landau, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
    Blood (2023)

    Fulltext@MSK | Save